Search database
Filter
3024
Text search: drug distribution guidelines
Featured
Language
Document type
1989
396
372
108
96
26
22
12
2
1
Countries
160
115
93
84
83
74
73
64
64
60
60
60
58
51
49
45
44
40
39
35
34
33
31
30
29
26
26
20
20
19
18
17
15
13
12
12
12
11
10
10
9
9
8
7
7
7
7
7
7
6
6
6
6
6
5
5
5
5
5
5
4
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
353
217
169
101
82
71
65
56
46
44
28
26
22
21
19
18
18
18
17
15
15
15
14
13
13
13
12
12
11
11
10
10
10
9
9
9
9
9
8
8
8
8
8
8
8
7
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Publication Years
Category
1320
281
166
119
56
52
42
1
1
1
Toolboxes
350
256
222
157
115
101
94
58
53
47
37
33
32
30
28
20
13
13
9
9
8
7
1
1
 Add to my MEDBOX

Guidelines on management of blood and blood components as essential medicines

World Health Organization WHO (2017) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Coronavirus SARS-CoV-2/ COVID-19 Pandemic: Information and interim guidelines for pharmacists and the pharmacy workforce

International Pharmaceutical Federation (FIP) (2020) CC
The purpose of this document is to provide relevant information and guidelines on coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, b ... more
 Download
  View PDF
 Add to my MEDBOX

WHO Drug Information - Volume 36, No. 4

World Health Organisation (WHO) (2023) C_WHO
Pharmaceutical News Evaluation of Saccharide Content of the WHO 2nd International Standard for Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP) by HPAECPAD Analysis Following Acid Hydrolysis Consultation Documents Lamivudine and tenofovir disoproxil fumarate tablets (lami ... more
 External Link
 Add to my MEDBOX

Prevalence and distribution of schistosomiasis in human, livestock, and snail populations in northern Senegal: a One Health epidemiological study of a multi-host system

Léger, E.; Borlase, A.; Fall, C. et al. The Lancet Planetary Health (2020) CC
Schistosomiasis is a neglected tropical disease of global medical and veterinary importance. As efforts to eliminate schistosomiasis as a public health problem and interrupt transmission gather momentum, the potential zoonotic risk posed by livestock Schistosoma species via viable hybridisation in s ... more
 Add to my MEDBOX

Guidelines for the prevention, management and care of diabetes mellitus

World Health Organization WHO (2006) C_WHO
Diabetes mellitus is one of the most common noncommunicable diseases worldwide. In the Eastern Mediterranean Region there has been a rapid increase in the incidence of diabetes mellitus and it is now the fourth leading cause of death. The increasing prevalence of diabetes mellitus, the emergence of ... more
 Download
  View PDF
 Add to my MEDBOX

Prevention of Drug Use and Treatment of Drug Use Disorders in Rural Settings
recommended

United Nations Office on Drug and Crime UNODC (2017) C1
 Download
  View PDF
 Add to my MEDBOX

Staying alive: safety and security guidelines for humanitarian volunteers in conflict areas

David Lloyd Roberts International Comitee of the Red Cross (ICRC) (2005) C1
With its expert practical advice on security in situations of armed conflict, this updated set of guidelines will prove invaluable to humanitarian personnel working at the operational level. Following on from the success of the first edition, publis ... more
 Download
  View PDF
 Add to my MEDBOX

Guidelines for Addressing HIV in Humanitarian Settings (IASC)
recommended

Inter-Agency Standing Committee UNAIDS (2010)
 Download
  View PDF
 Add to my MEDBOX

Guidelines Storage Essential Medicines And Other Health Commodities

World Health Organization WHO; Deliver; UNICEF (2006) C_WHO
Maintaining proper storage conditions for health commodities is vital to ensuring their quality. Product expiration dates are based on ideal storage conditions and protecting product quality until their expiration date is important for serving customers and conserving resources. ... more
 Download
  View PDF
 Add to my MEDBOX

Guidelines For The Control Of Epidemics Due To Shigella Dysenteriae Type 1

World Health Organization (1995)
 Add to my MEDBOX

How To Add Deworming To Vitamin A Distribution

World Health Organization, UNICEF (2004)
 Add to my MEDBOX

Guidelines for the Integrated Management of Severe Acute Malnutrition

ACF International (2011)
In-and Out-Patient Treatment
 Download
  View PDF
 Add to my MEDBOX

Guidelines for Implementing Interagency Health and Nutrition Evaluations in Humanitarian Crises

Interagency Health and Nutrition Evaluations in Humanitarian Crises (IHE) Initiative UNHCR (2007)
 Download
  View PDF
 Add to my MEDBOX

Indian Public Health Standards (IPHS) Guidelines for Primary Health Centres

Directorate General of Health Services Ministry of Health & Family Welfare Government of India Directorate General of Health Services Ministry of Health & Family Welfare Government of India (2012) C1
 Download
  View PDF
 Add to my MEDBOX

DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended

Médecins sans Frontières (2016) C_WHO
4th edition. This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of ... more
 Download
  View PDF
 Add to my MEDBOX

Internal Medicine Clinical treatment guidelines

Ministry of Health, Rwanda (2012)
 Download
  View PDF
 Add to my MEDBOX

Hospice palliative care association of South Africa clinical guidelines
recommended

Hospice Palliative Care Association of SOUTH AFRICA (2012) C1
 Download
  View PDF
 Add to my MEDBOX

GUIDELINES FOR THE MANAGEMENT, PREVENTION & CONTROL OF MENINGOCOCCAL DISEASE IN SOUTH AFRICA

Dept. of Health, Republic of South Africa (2011) C1
 Download
  View PDF
 Add to my MEDBOX

National Health Strategy and Guidelines for Bangladesh

Ministry of Health and Family Welfare, Government of the People's Republic of Bangladesh (2009) C1
 Download
  View PDF
 Add to my MEDBOX

Public Health Emergency Management Guidelines for Ethiopia 2012

Ethiopian Health and Nutrition Research Institute Public Health Emergency Management Centre (2012) C1
 Download
  View PDF
 Add to my MEDBOX

Kenya national palliative care guidelines
recommended

Republic of Kenya, Ministry of Health (2013) C1
 Download
  View PDF
 Add to my MEDBOX

2014 PHA Clinical Practice Guidelines for the Diagnosis and Management of Patients with Coronary Artery Disease
recommended

Liberty O. Yaneza, Ma. Consolacion Dolor-Torres, Sue Ann R. Locnen Philippine Heart Association (2014) C1
 Download
  View PDF
 Add to my MEDBOX

Guidelines for Rogi Kalyan Samities in Public Health Facilities

National Health Mission; Ministry of Health & Social Welfare India (2015) C1
 Download
  View PDF
 Add to my MEDBOX

Nigeria: National Drug Control Master Plan (NDCMP) 2015-2019

United Office of Drugs and Crime, National Coordinating Unit Nigeria (2015) C1
 Download
  View PDF
 Add to my MEDBOX

Guidelines on the local government planning process health sector supplement

Ministry of Health Uganda (2016) C1
 Download
  View PDF
 Add to my MEDBOX

National Neonatal Health Strategy and Guidelines for Bangladesh

Ministry of Health and Family Welfare Government of the People's Republic of Bangladesh (2009) C1
 Download
  View PDF
 Add to my MEDBOX

South Africa: National Parenteral Nutrition Practice Guidelines for Paediatrics

National Department of Health, Republic of South Africa (2016) C2
 Download
  View PDF
 Add to my MEDBOX

Framework for the engagement of all health care providers in the management of drug resistant tuberculosis

World Health Organization (2015) C_WHO
The END TB strategy
 Download
  View PDF
 Add to my MEDBOX

TIP 18: The Tuberculosis Epidemic: Legal and Ethical Issues for Alcohol and Other Drug Treatment Providers: Treatment Improvement Protocol (TIP) Series 18

D. H. Mulligan, U.S Department of health and human service (1995) C2
 Download
  View PDF
 Add to my MEDBOX

Surveillance of HIV drug resistance in children newly diagnosed with HIV by early infant diagnosis. Concepte Note

World Health Organization WHO (2017) C_WHO
This concept note describes the methods used to assess the prevalence of any HIVDR and HIVDR by PMTCT exposure among children less than 18 months of age using remnant dried blood spot specimens from early infant diagnosis over a 12-month period
 Download
  View PDF
 Add to my MEDBOX

Community Mental Health - Implementation Guidelines
recommended

Christoffel-Blindenmission (CBM) (2010)
 Download
  View PDF
 Add to my MEDBOX

Guidelines on Chemical Management in Health Care Facilities

Ministry of Health Malaysia (2010) C1
Specific Objectives • To increase the knowledge and awareness of personnel on chemical management. • To educate the personnel on the potential adverse health effects of chemical exposure. • To educate the personnel on the existing laws pertaining to handling of hazardous chemicals. • To ... more
 Download
  View PDF
 Add to my MEDBOX

Guidelines on the Conservation of Medicinal Plants

International Union for Conservation of Nature and Natural Resources (IUCN), World Health Organization (WHO) (1993) C_WHO
The aim of these Guidelines is to provide a framework for the conservation and sustainable use of plants in medicine. To do this, the Guidelines describe the various tasks that should be carried out ... more
 Download
  View PDF
 Add to my MEDBOX

Approaches for mobile and migrant populations in the context of malaria multi-drug resistance and malaria elimination in the Greater Mekong Subregion

World Health Organization ( WHO), Regional Office for South-East-Asia (2016) C_WHO
The emergence of multifrug-resistant malaria in the Greater Mekong Subregion (‎GMS)‎ has been identified as an emergency issue that may have catastrophic consequences on the future of malaria elimination in the GMS as well as globally. In recognition of the need for a cohesive regional response, ... more
 Download
  View PDF
 Add to my MEDBOX

WHO recommendations on maternal health: Guidelines approved by the WHO Guidelines Review Committee

World Health Organization (WHO) (2017) C_WHO
Updated May 2017
This document is meant to respond to the questions:
■ What health interventions should be delivered during pregnancy, childbirth and the postnatal period?
■ What health behaviours should the women practise (or not practise) during these periods to care for ... more
 Download
  View PDF
 Add to my MEDBOX

WHO recommendations on adolescent health: guidelines approved by the WHO Guidelines Review Committee

World Health Organization (WHO) (2017) C_WHO
This document is meant to respond to the questions:
■ What health interventions should the adolescent receive and when should s/he receive it?
■ What health behaviours should the adolescent practise (or not practise)?
 Download
  View PDF
 Add to my MEDBOX

GUIDELINES FOR GOOD CLINICAL LABORATORY PRACTICES (GCLP)

Indian Council of Medical Research (ICMR) (2008) C1
Guidelines for Good Clinical Laboratory Practices (GCLP) outlines the principles and procedures to be followed by medical laboratories involved in clinical research and/or patient care so as to provide quality data which can be used for health resea ... more
 Download
  View PDF
 Add to my MEDBOX

Bosnia and Herzegovina - National Drug Situation Report 2017

European Monitoring Centre for Drugs and Drug Addiction (2018) C2
 Download
  View PDF
 Add to my MEDBOX

Philippine National Drug Formulary - Essential Medicines List, Volume I (7th Edition)

The National Formulary Committee, National Drug Policy, DOH Philippines (2008) C1
 Download
  View PDF
 Add to my MEDBOX

Guidelines for the diagnosis and treatment of Chagas disease
recommended

World Health Organization WHO (2019) C_WHO
This document focuses on making recommendations for the diagnosis and treatment of Chagas disease, an infection caused by Trypanosoma cruzi, the protozoan agent of a systemic parasitic disease. Methodology: These clinical practice guidelines were pr ... more
 Download
  View PDF
 Add to my MEDBOX

The impact of drug policy on health and human rights in Eastern Europe

M. Hoekstra Eurasian Harm Reduction Network (2009) C2
10 years after the UN general assembly special session on drugs
 External Link
 Add to my MEDBOX

Retest and treat: a review of national HIV retesting guidelines to inform elimination of mother-to-child HIV transmission (EMTCT) efforts

A. L. Drake; K. A. Thomson; C. Quinn; et al. Journal of the International AIDS Society; PubMed.gov (2019) C2
Review Drake AL et al. Journal of the International AIDS Society 2019, 22:e25271 http://onlinelibrary.wiley.com/doi/10.1002/jia2.25271/full | https://doi.org/10.1002/jia2.25271
 Download
  View PDF
 Add to my MEDBOX

Guidelines forPrevention and Management of Stroke
recommended

National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases & Stroke (NPCDCS), India (2019) C2
 Download
  View PDF
 Add to my MEDBOX

Guidelines for Addressing HIV in Humanitarian Settings

UNAIDS; IASC (Inter-Agency Standing Committee) (2010) C2
UNAIDS/10.03E / JC1767E (English original, March 2010) ISBN 978 92 9 173849 6
 Download
  View PDF
 Add to my MEDBOX

Guidelines on Use of Antiretroviral Drugs for Treating and Preventing HIV in Kenya

Ministry of Health; National AIDS & STI Control Program (2018) C2
2018 Edition
 Add to my MEDBOX

Guidelines for Risk Analysis of Foodborne Antimicrobial Resistance

Food and Agriculture Organization of the United Nations FAO (2021) CC
Antimicrobial resistance (AMR) is a major global public health concern and a food safety issue. When pathogens become resistant to antimicrobial agents they can pose a greater human health risk as a result of potential treatment failure, loss of treatment options and increased likelihood and severi ... more
 Add to my MEDBOX

Securing the future from drug-resistant infections

Interagency Coordination Group on Antimicrobial Resistance IAGG World Health Organisation WHO (2019) C_WHO
Antimicrobial resistance is a global crisis that threatens a century of progress in health and achievement of the Sustainable Development Goals. There is no time to wait. Unless the world acts urgently, antimicrobial resistance will have disastrous impact within a generation.
 Add to my MEDBOX

Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended

World Health Organization WHO (2020) C_WHO
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people ... more
 Add to my MEDBOX

Considerations for introducing new antiretroviral drug formulations for children

World Health Organization WHO (2020) CC
Policy brief. July 2020
 Download
  View PDF
 Add to my MEDBOX

Guidelines for emergency and compassionate use authorisation of health products and technologies

Ministry of Health, Kenya (2020) CC
 Add to my MEDBOX

Guidelines for establishing a poison centre

World Health Organization WHO (2020) C_WHO
This update of the Guidelines for poison control, entitled Guidelines for establishing a poison centre, reflects the development of the role of poison centres in public health and the sound manageme ... more
 Download
  View PDF
 Add to my MEDBOX

International standards for the treatment of drug use disorders - Revised Edition Incorporating Results Of Field - Testing

World Health Organization WHO (2020) C_WHO
This document is based on currently available scientific evidence on treatment for drug use disorders and sets out a framework for the implementation of the Standards, in line with principles of public health care. The Standards identify major compo ... more
 Download
  View PDF
 Add to my MEDBOX

Primary Health Care Network Guidelines

Kenya Ministry of Health (2021) C1
 External Link
 Add to my MEDBOX

Training in monitoring and epidemiological assessment of mass drug administration for eliminating lymphatic filariasis: learners’ guide

World Health Organization WHO; Institutional research information sharing iris (2013) C_WHO
Training in monitoring and epidemiological assessment of mass drug administration for eliminating lymphatic filariasis: learners’ guide. World Health Organization.
 Download
  View PDF
 Add to my MEDBOX

Guidelines for the Implementation of the SHA 2011 Framework for Accounting Health Care Financing

Organisation for Economic Co-operation and Development (OECD) and World Health Organization (WHO) Organisation for Economic Co-operation and Development (OECD) and World Health Organization (WHO) (2014) CC
The accounting framework for health care financing is a key component of A System of Health Accounts 2011, published by OECD, Eurostat and WHO in October 2011.1 The framework makes health accounts more adaptable to rapidly evolving health financing systems, further enhances crosscountry comparabilit ... more
 Download
  View PDF
 Add to my MEDBOX

West Nile Virus in the United States: Guidelines for Surveillance, Prevention, and Control

Centers for Disease Control and Prevention (2013)
 Download
  View PDF
 Add to my MEDBOX

Health and social welfare sector public private partnerships policy guidelines

Ministry of Health and Social Welfare, Tanzania (2013) CC
 Download
  View PDF
 Add to my MEDBOX

South Africa’s protracted struggle for equal distribution and equitable access – still not there

Hendrik CJ van Rensburg (2014) CC
 Download
  View PDF
 Add to my MEDBOX

Roadmap to prevent and combat drug-resistant tuberculosis

World Health Organization Europe (2011) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Global action plan on HIV drug resistance 2017–2021

World Health Organization (WHO) (2017) C_WHO
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant ... more
 Download
  View PDF
 Add to my MEDBOX

International Standards for the Treatment of Drug Use Disorders
recommended

World Health Organization, United Nations Office on Drugs and Crime (2017) C2
 Download
  View PDF
 Add to my MEDBOX

No Time to Wait: Securing the future from drug-resistant infections

IACG Interagency Coordination Group on Antimicral Resistance (2019) C_WHO
UN, international agencies and experts released a groundbreaking report demanding immediate, coordinated and ambitious action to avert a potentially disastrous drug-resistance crisis. If no action is taken - warns the UN Ad hoc Interagency Coordin ... more
 Download
  View PDF
 Add to my MEDBOX

No Time to Wait: Securing the future from drug-resistant infections. Summary of recommendations and key messages

IACG Interagency Coordination Group on Antimicral Resistance (2019) C_WHO
Available in English, French, Spanish, Russian, Chinese, Arabic and Portugues
 Download
  View PDF
 Add to my MEDBOX

Clinical, Virologic, Immunologic Outcomes and Emerging HIV Drug Resistance Patterns in Children and Adolescents in Public ART Care in Zimbabwe

A. T. Makadzange; M. Higgins-Biddle; B. Chimukangara; et al. PLOS One (2015) CC
PLOS ONE | DOI:10.1371/journal.pone.0144057 December 14, 2015
 Download
  View PDF
 Add to my MEDBOX

The Public Health Dimension of the World Drug problem

World Health Organization WHO (2019) C_WHO
How WHO works to prevent drug use, reduce harm and improve safe access to medicines
 Download
  View PDF
 Add to my MEDBOX

Vietnam: National Action Plan on Combating Drug Resistance in the period from 2013 - 2020

Ministry of Health Vietnam (2013) C2
In Vietnam, most of the examination and treatment facilities are facing with of spread of bacteria resistant to many antibiotics. The level and speed of drug resistance are increasing, at alarming level. The burden of ... more
 Download
  View PDF
 Add to my MEDBOX

Line probe assays for detection of drug-resistant tuberculosis: interpretation and reporting manual for laboratory staff and clinicians

World Health Organization WHO (2022) C_WHO
 Download
  View PDF
 Add to my MEDBOX

The impact of residual infections on Anopheles-transmitted Wuchereria bancrofti after multiple rounds of mass drug administration

D. K. de Souza; Ansumana, R.; Sessay, S.; et al. Parasites & Vectors (2015) CC
Many countries have made significant progress in the implementation of World Health Organization recommended preventive chemotherapy strategy, to eliminate lymphatic filariasis (LF). However, pertinent challenges such as the existence of areas of residual infections in disease endemic districts pose ... more
 Download
  View PDF
 Add to my MEDBOX

Strategy to respond to antimalarial drug resistance in Africa

World Health Organization WHO (2022) C_WHO
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial ... more
 Download
  View PDF
 Add to my MEDBOX

Strategic plan for the prevention and control of multidrug-resistant and extensively drug-resistant tuberculosis in the Eastern Mediterranean Region (2010–2015)

World Health Organization Eastern Mediterranean (2010) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Infection prevention, control and surveillance: Limiting the development and spread of drug-resistance

O’Neill, J. Review on Antimicrobial Resistance (2016) C1
 Download
  View PDF
 Add to my MEDBOX

Harsh punishment - The Human Toll of Georgia’s Abusive Drug Policies

G. Gogia Human Rights Watch (2018) C2
 Download
  View PDF
 Add to my MEDBOX

Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis

World Health Organization (2017) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Good Practices in strengthening health systems for the prevention and care of Tuberculosis and drug-resistant Tuberculosis

World Health Organization, Europe (2016) C_WHO
 Download
  View PDF
 Add to my MEDBOX

3MDG Maternal, Newborn and Child Health Indicator Guidelines [2nd ed.]

Three Millennium Development Goal Fund (3MDG) (2016) C1
Version 2, January 2016
The primary purpose of this document is to provide 3MDG stakeholders with some essential information on the MNCH core-indicators for 3MDG, which were derived from the 3MDG Logical Framework, Data Dictionary for Health Service Indicators (2014 June, DoPH, MoH), A ... (MEASURE Evaluation, September 2005) and Monitoring Emergency Obstetric Care (WHO/UNICEF/UNFPA/AMDD). Partners are strongly encouraged to integrate the MNCH indicators into their ongoing monitoring and evaluation (M&E) activities.
These indicators are designed to help Partners assess the current state of their activities, their progress towards achieving their targets, and contribution towards the national response. This guideline is designed to improve the quality and consistency of data collected at the township level, which will enhance the accuracy of conclusions drawn when the data are aggregated. more
 Download
  View PDF
 Add to my MEDBOX

Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis

World Health Organization WHO (2021) CC
Meeting Report 27-29 October 2020 The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this ... more
 Download
  View PDF
 Add to my MEDBOX

Uganda: Integrated Community Case Management of Childhood Malaria, Pneumonia and Diarrhoea - Implementation Guidelines

World Health Organization WHO; UNICEF; Ministry of Health Uganda (2010) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Lao People’s Democratic Republic-WHO Country Cooperation Strategy 2024–2028

World Health Organization WHO (2023) C_WHO
This country cooperation strategy (CCS) outlines how the World Health Organization (WHO) will work with the Lao People’s Democratic Republic over the next five years (2024–2028), supporting the implementation of the five-year health sector development plans and the Health Sector Reform Strategy ... more
 Download
  View PDF
 Add to my MEDBOX

GUIDELINES FOR RECALL OF MEDICINES AND HEALTH PRODUCTS IN MALAWI

Pharmacy, Medicines & Poisons Board (PMPB), Malawi (2015) C2
PMPB/INS-GUIDE/02
 Add to my MEDBOX

Antimicrobials use, reistance and containment baseline survey (Ethiopia)

Drug Administration and Control Authority of Ethiopia , et al. (2009) C1
Emergence of antimicrobial resistance is a result of the use, overuse and misuse of antibiotics both in humans and animals. In Ethiopia, there are indications on the misuse of antibiotics by health care providers’, unskilled practitioners, and drug ... more
 Download
  View PDF
 Add to my MEDBOX

Models for the legal supply of cannabis: recent developments

European Monitoring Centre for Drugs and Drug Addiction (2016) C2
Perspective on drugs
 Add to my MEDBOX

Maldives National Action Plan for Containment of Antimicrobial Resistance 2017-2022

Maldives Food and Drug Authority Ministry of Health (2017) C2
Maldives has made significant strides in the area of infectious disease prevention and control. This is exemplified by elimination of malaria from Maldives in 2015 and successes in TB control. In addition, Maldives is a front runner in infectious disease prevention through successful water, sanitati ... more
 Add to my MEDBOX

Enhancing Pharmacovigilance in Sub‑Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi

Jusot, V.; Chimimba, F.; Dzabala, N. et al. Drug Safety (2020) CC
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV. Objective The objective of this initi ... more
 Download
  View PDF
 Add to my MEDBOX

Strategies to prevent diversion of opioid substitution treatment medications

European Monitoring Centre for Drugs and Drug Addiction (2016) C2
Perspectives on Drugs
 Download
  View PDF
 Add to my MEDBOX

Uganda: Annual Pharmacovigilance Report July 2015 – June 2016

National Drug Authority, Uganda (2016) C1
 Download
  View PDF
 Add to my MEDBOX

Country overview: Uzbekistan

European Monitoring Centre for Drugs and Drug Addiction (2015) C2
 Download
  View PDF
 Add to my MEDBOX

New heroin-assisted treatment - Recent evidence and current practices of supervised injectable heroin treatment in Europe and beyond

J. Strang; T. Groshkova; N. Metrebian European Monitoring Centre for Drugs and Drug Addiction; Publications Office (2019) C2
EMCDDA Insights - 11 Accessed: 14.03.2019
 Download
  View PDF
 Add to my MEDBOX

EMCDDA Monographs

T. Rhodes; D. Hedrich European Monitoring Centre for Drugs and Drug Addiction (2010) C2
Harm reduction: evidence, impacts and challenges -10-
 Download
  View PDF
 Add to my MEDBOX

Country overview: Georgia

J.D. Javakhishvili; L. Sturua; I. Kirtadze; et al. European Monitoring Centre for Drugs and Drug Addiction (2015) C2
 Download
  View PDF
 Add to my MEDBOX

Montenegro country overview

J. Sekulić European Monitoring Centre for Drugs and Drug Addiction (2011) C2
A summary of the national drug situation
 Download
  View PDF
 Add to my MEDBOX

Prevention and control of blood- borne viruses in prison settings

European Centre for Disease Prevention and Control; European Monitoring Centre for Drugs and Drug Addiction (2018) C2
Guidance Brief Selected findings from ECDC and EMCDDA scientific guidance, 2018
 Download
  View PDF
 Add to my MEDBOX

HIV in prisons Situation and needs assessment toolkit

United Nations Office4 on Drugs and Crime; European Monitoring Centre for Drugs and Drug Addiction (2010) C2
Advance copy.
 Download
  View PDF
 Add to my MEDBOX

Technical update on treatment optimization: use of efavirenz during pregnancy: a public health perspective

World Health Organization (2012) C_WHO
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organ ... more
 Add to my MEDBOX

Management of MDR-TB: A field guide

Partners in Health, World Health Organization (2009) C_WHO
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) increasingly occur in resource-constrained settings. In the context of a national response to MDR- and XDR-TB, health workers in TB clinics (in distric ... more
 Download
  View PDF
 Add to my MEDBOX

Revised WHO classification and treatment of childhood pneumonia at health facilities

World Health Organization (2014)
The revised guidelines present two major changes to existing guidelines: (A) there are now just 2 categories of pneumonia instead of 3 (“pneumonia” which is treated at home with oral amoxicillin ... more
 Download
  View PDF
 Add to my MEDBOX

WHO best practices for injections and related procedures toolkit

World Health Organization; SIGN (2010) C_WHO
The WHO guidelines provide recommended steps for safe phlebotomy and reiterate accepted principles for drawing, collecting blood and transporting blood to laboratories/blood banks.
 External Link
 Add to my MEDBOX

Guideline on when to start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV

Elaine Abrams, Tsitsi Apollo, Janet Bhila et al. World Health Organization WHO (2015) C_WHO
The new WHO guidelines recommend that people living with HIV be started on antiretrovirals (ARVs) as soon as possible after being diagnosed. Currently, many people living with the virus globally must wait until their CD4 counts fall to 500 to start ... more
 Download
  View PDF
 Add to my MEDBOX

Xpert MTB/RIF test Rollout and Implementation Plan

National Tuberculosis and Leprosy Programme Ministry of Health and Social Welfare, Tanzania (2016) C1
The overall objective of this implementation plan is to define the strategy for implementation of the Xpert MTB/RIF test for rapid detection of TB and rifampicin (RIF) resistance in Tanzania, within the context of the National Tuberculosis and Leprosy Programme (NTLP) strategic plan and other nation ... more
 Download
  View PDF
 Add to my MEDBOX

Manual for the Health Care of Children in Humanitarian Emergencies

World Health Organization WHO (2008) C_WHO
This manual was developed based on the recommendations of a global technical consultation on child health in humanitarian emergencies co-organized by WHO and UNICEF at the end of 2003. WHO in collaboration with the Centre for Refugee and Disaster Response, Bloomberg School of Public Health, Johns Ho ... more
 Download
  View PDF
 Add to my MEDBOX

Control of Epidemic Meningococcal Disease

World Health Organization (1998)
WHO practical guidelines. 2nd edition